Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP545192.RAYEaVt47QGWxDvK2Id54vyGawe2hgAMeljFuAtovbuzY130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545192.RAYEaVt47QGWxDvK2Id54vyGawe2hgAMeljFuAtovbuzY130_provenance.
• NP493409.RAlT5vBbHvMWeyaudcbId_eRKMhVFyaktHTt88AguXsXs130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493409.RAlT5vBbHvMWeyaudcbId_eRKMhVFyaktHTt88AguXsXs130_provenance.
• NP806527.RAku9omYTHiswFLc4IidoTnOJk1h9bDmnkW1xC8UxyOLM130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806527.RAku9omYTHiswFLc4IidoTnOJk1h9bDmnkW1xC8UxyOLM130_provenance.
• NP391461.RALf02Pj9QS-i-xRcAQdPHoUfRP79N2MaqfbrkhQWeBuw130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391461.RALf02Pj9QS-i-xRcAQdPHoUfRP79N2MaqfbrkhQWeBuw130_provenance.
• NP291483.RAd4IZxV1NvtAnpnrtUarcsPrW7Gp3rqHeA_u9jpLQmvs130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291483.RAd4IZxV1NvtAnpnrtUarcsPrW7Gp3rqHeA_u9jpLQmvs130_provenance.
• NP333841.RAeho59bfKcC971b8eJNv9wPKsxND3iZNBn5UF4dGRTGg130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333841.RAeho59bfKcC971b8eJNv9wPKsxND3iZNBn5UF4dGRTGg130_provenance.
• NP295452.RAbTVNqYNDU6oEZeATCf5OMeFlBL-X3kz3WIKL4gFZnrA130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295452.RAbTVNqYNDU6oEZeATCf5OMeFlBL-X3kz3WIKL4gFZnrA130_provenance.
• NP790345.RAP7Szhfch569XeZ-UsqZANNyDg_Gw0p4giNVGzEHIhsw130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790345.RAP7Szhfch569XeZ-UsqZANNyDg_Gw0p4giNVGzEHIhsw130_provenance.
• NP333836.RAtkykG0qPb8vpWQSCXvPwTnsdr7lr-0x-vZLSzHWL0Yw130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333836.RAtkykG0qPb8vpWQSCXvPwTnsdr7lr-0x-vZLSzHWL0Yw130_provenance.
• NP333944.RAs42nLMNIINv50C2ZqpwQBvdRWULf_V_xm312zKL0tfQ130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333944.RAs42nLMNIINv50C2ZqpwQBvdRWULf_V_xm312zKL0tfQ130_provenance.
• NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_provenance.
• NP291686.RAwHHtVRJwzWxksYUPzQo5mTfdxuG1RocBNeGpLPQlzCU130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291686.RAwHHtVRJwzWxksYUPzQo5mTfdxuG1RocBNeGpLPQlzCU130_provenance.
• NP295061.RA9XtoTI_GgCNdgczJBLd622SZDZ9iAR1JiipjY9cvIIw130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295061.RA9XtoTI_GgCNdgczJBLd622SZDZ9iAR1JiipjY9cvIIw130_provenance.
• NP335190.RA0lC4ov_6nhJtnJnQ8peIMdFCEKxtMII3gtuFTz1opgs130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335190.RA0lC4ov_6nhJtnJnQ8peIMdFCEKxtMII3gtuFTz1opgs130_provenance.